Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I undergo during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my symptoms be assessed throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I do if my symptoms worsen while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel requirements or restrictions during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Targeting Pro-Inflammatory Cells in Idiopathic Pulmonary Fibrosis: a Human Trial clinical trial (NCT02874989). Contact the study team or your healthcare provider for specific answers.

What this study is about